Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Abstract Background Olfactory neuroblastoma is a rare malignancy of the anterior skull base typically treated with surgery and adjuvant radiation. Although outcomes are fair for low-grade disease, patients with high-grade, recurrent, or metastatic disease oftentimes respond poorly to standard treatm...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins, Wiem Lassoued, Kenneth Canubas, Andrew Warner, Baktiar Karim, Ksenia Vulikh, James W. Hodge, Charalampos S. Floudas, James L. Gulley, Gary L. Gallia, Clint T. Allen, Nyall R. London
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2024-05-01
Cyfres:	Journal of Translational Medicine
Pynciau:	Esthesioneuroblastoma Immunotherapy Olfactory neuroblastoma
Mynediad Ar-lein:	https://doi.org/10.1186/s12967-024-05339-9
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!